Medtech innovation

Phraxis Announces First-Ever Commercial Case of EndoForce Anastomotic Connector

The technology is compatible with all PTFE grafts and was studied extensively in the company's pivotal clinical trial...

RaySearch launches RayIntelligence v2025

With the new customisation tools, clinics can create dashboards that reflect their operations and priorities, from plan quality trends and machine utilisation to protocol adherence and outcome signals...

Abbott’s Navitor™ Wins CE Mark Expansion, Offering Minimally Invasive Valve Replacement to Low- and Intermediate-Risk Patients in Europe

Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management....

Nicklaus Children's Heart Institute First to Offer Innovative Heart Stent Designed for Babies

New FDA-approved Minima Stent grows with a child's heart, preventing the need for open heart surgeries...

Healthium Medtech and C-CAMP Launch First Cohort of Flagship Innovations Program

The partnership aims to foster deep-science innovations in digitally enabled medical technologies that are affordable, scalable and clinically impactful...

Datasea Achieves Breakthrough in Acoustic Technology

DTSS's acoustic innovation addresses the healthcare application market projected to exceed $100 billion in China and approach $90 billion globally by 2030...

Philips to Invest Over USD 150 Million in U.S. Manufacturing and AI-Powered Health Technology R&D

Expansion of facilities in Pennsylvania and Minnesota aims to boost production of AI-enabled ultrasound and image-guided therapy solutions, creating over 270 new jobs....

DeepSight™ Technology Receives First FDA 510(k) Clearance for NeedleVue™ LC1 Ultrasound System

Bringing Clarity and Confidence to Ultrasound-Guided Interventional Procedures ...

OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer

Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device....

Myra Vision Gains FDA Approval to Begin IDE Study for Glaucoma Therapy System

Trial to assess Calibreye™ Titratable Glaucoma Therapy™ Surgical System in refractory glaucoma patients ...